These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31685464)

  • 21. Genetic environments and related transposable elements of novel cfr(C) variants in Campylobacter coli isolates of swine origin.
    Tang Y; Lai Y; Yang X; Cao X; Hu Y; Wang X; Wang H
    Vet Microbiol; 2020 Aug; 247():108792. PubMed ID: 32768235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Clostridium difficile Lineage Endemic to Costa Rican Hospitals Is Multidrug Resistant by Acquisition of Chromosomal Mutations and Novel Mobile Genetic Elements.
    Ramírez-Vargas G; Quesada-Gómez C; Acuña-Amador L; López-Ureña D; Murillo T; Del Mar Gamboa-Coronado M; Chaves-Olarte E; Thomson N; Rodríguez-Cavallini E; Rodríguez C
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance mechanisms of linezolid-nonsusceptible enterococci in Korea: low rate of 23S rRNA mutations in Enterococcus faecium.
    Lee SM; Huh HJ; Song DJ; Shim HJ; Park KS; Kang CI; Ki CS; Lee NY
    J Med Microbiol; 2017 Dec; 66(12):1730-1735. PubMed ID: 29111969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights into the structure, function and evolution of the radical-SAM 23S rRNA methyltransferase Cfr that confers antibiotic resistance in bacteria.
    Kaminska KH; Purta E; Hansen LH; Bujnicki JM; Vester B; Long KS
    Nucleic Acids Res; 2010 Mar; 38(5):1652-63. PubMed ID: 20007606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic resistance of clinical isolates of Clostridioides difficile in China and its association with geographical regions and patient age.
    Li H; Li WG; Zhang WZ; Yu SB; Liu ZJ; Zhang X; Wu Y; Lu JX
    Anaerobe; 2019 Dec; 60():102094. PubMed ID: 31499177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria.
    Schwarz S; Zhang W; Du XD; Krüger H; Feßler AT; Ma S; Zhu Y; Wu C; Shen J; Wang Y
    Clin Microbiol Rev; 2021 Jun; 34(3):e0018820. PubMed ID: 34076490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of a genetic linkage between genes coding for resistance to tetracycline and erythromycin in Clostridium difficile.
    Spigaglia P; Barbanti F; Mastrantonio P
    Microb Drug Resist; 2007; 13(2):90-5. PubMed ID: 17650959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The recognition and characterisation of Finnish Clostridium difficile isolates resembling PCR-ribotype 027.
    Krutova M; Nyc O; Matejkova J; Kuijper EJ; Jalava J; Mentula S
    J Microbiol Immunol Infect; 2018 Jun; 51(3):344-351. PubMed ID: 28583353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular epidemiologic study of Clostridium difficile infections in university hospitals: Results of a nationwide study in Japan.
    Tokimatsu I; Shigemura K; Osawa K; Kinugawa S; Kitagawa K; Nakanishi N; Yoshida H; Arakawa S; Fujisawa M;
    J Infect Chemother; 2018 Aug; 24(8):641-647. PubMed ID: 29685855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolving oxazolidinone resistance mechanisms in a worldwide collection of enterococcal clinical isolates: results from the SENTRY Antimicrobial Surveillance Program.
    Deshpande LM; Castanheira M; Flamm RK; Mendes RE
    J Antimicrob Chemother; 2018 Sep; 73(9):2314-2322. PubMed ID: 29878213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A nationwide study of molecular epidemiology and antimicrobial susceptibility of Clostridioides difficile in South Korea.
    Byun JH; Kim H; Kim JL; Kim D; Jeong SH; Shin JH; Kim YA; Shin JH; Shin KS; Uh Y
    Anaerobe; 2019 Dec; 60():102106. PubMed ID: 31655214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linezolid-resistant clinical isolates of enterococci and Staphylococcus cohnii from a multicentre study in China: molecular epidemiology and resistance mechanisms.
    Chen H; Wu W; Ni M; Liu Y; Zhang J; Xia F; He W; Wang Q; Wang Z; Cao B; Wang H
    Int J Antimicrob Agents; 2013 Oct; 42(4):317-21. PubMed ID: 23880167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low fitness cost of the multidrug resistance gene cfr.
    LaMarre JM; Locke JB; Shaw KJ; Mankin AS
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3714-9. PubMed ID: 21646483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characterization of Clostridium difficile isolated from carriage and association of its pathogenicity to prevalent toxic genes.
    Abuderman AA; Mateen A; Syed R; Sawsan Aloahd M
    Microb Pathog; 2018 Jul; 120():1-7. PubMed ID: 29684543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial resistance in large clostridial toxin-negative, binary toxin-positive Clostridium difficile ribotypes.
    Androga GO; Knight DR; Lim SC; Foster NF; Riley TV
    Anaerobe; 2018 Dec; 54():55-60. PubMed ID: 30053486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic analysis of Tn916-like elements conferring tetracycline resistance in clinical isolates of Clostridium difficile.
    Dong D; Chen X; Jiang C; Zhang L; Cai G; Han L; Wang X; Mao E; Peng Y
    Int J Antimicrob Agents; 2014 Jan; 43(1):73-7. PubMed ID: 24176599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New opportunities for improved ribotyping of C. difficile clinical isolates by exploring their genomes.
    Gürtler V; Grando D
    J Microbiol Methods; 2013 Jun; 93(3):257-72. PubMed ID: 23545446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe.
    Spigaglia P; Barbanti F; Mastrantonio P; Brazier JS; Barbut F; Delmée M; Kuijper E; R Poxton I; On Behalf Of The European Study Group On Esgcd
    J Med Microbiol; 2008 Jun; 57(Pt 6):784-789. PubMed ID: 18480338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diversity of multidrug-resistant epidemic Clostridium difficile NAP1/RT027/ST01 strains in tertiary hospitals from Honduras.
    Hidalgo-Villeda F; Tzoc E; Torres L; Bu E; Rodríguez C; Quesada-Gómez C
    Anaerobe; 2018 Aug; 52():75-78. PubMed ID: 29890209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characterization, toxin detection and resistance testing of human clinical Clostridium difficile isolates from Lebanon.
    Berger FK; Rasheed SS; Araj GF; Mahfouz R; Rimmani HH; Karaoui WR; Sharara AI; Dbaibo G; Becker SL; von Müller L; Bischoff M; Matar GM; Gärtner B
    Int J Med Microbiol; 2018 Apr; 308(3):358-363. PubMed ID: 29478838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.